12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several healthcare stocks saw significant movement. Bionomics (BNOX), Tempest Therapeutics (TPST), Sunshine Biopharma (SBFM), Lucy Scientific Discovery (LSDI), Societal CDMO (SCTL), and Celularity (CELU) saw their stocks rise, while Orgenesis (ORGS), SCWorx (WORX), Reshape Lifesciences (RSLS), Rain Oncology (RAIN), PaxMedica (PXMD), and TFF Pharmaceuticals (TFFP) saw their stocks fall.
August 28, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bionomics stock rose by 22.0% to $2.11.
The significant increase in Bionomics' stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Celularity stock rose 6.46% to $0.3.
The increase in Celularity's stock price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Lucy Scientific Discovery shares increased by 7.27% to $0.62.
The increase in Lucy Scientific Discovery's share price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Sunshine Biopharma shares increased by 7.91% to $0.44.
The rise in Sunshine Biopharma's share price indicates positive investor sentiment, which could result in further short-term gains.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Societal CDMO shares rose 6.64% to $0.47.
The rise in Societal CDMO's share price indicates positive investor sentiment, which could result in further short-term gains.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Tempest Therapeutics shares increased by 13.55% to $0.67.
The increase in Tempest Therapeutics' share price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Orgenesis shares decreased by 14.1% to $0.48.
The significant decrease in Orgenesis' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
PaxMedica stock decreased by 5.63% to $0.5.
The decrease in PaxMedica's stock price suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Rain Oncology stock declined by 5.71% to $0.99.
The decline in Rain Oncology's stock price suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Reshape Lifesciences stock fell 6.25% to $0.9.
The fall in Reshape Lifesciences' stock price indicates negative investor sentiment, which could result in further short-term losses.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
TFF Pharmaceuticals stock declined by 5.53% to $0.37.
The decline in TFF Pharmaceuticals' stock price suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
SCWorx shares decreased by 8.98% to $0.18.
The decrease in SCWorx's share price suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100